Ng HH, Bird A: DNA methylation and chromatin modification. Curr Opin Genet Dev. 1999, 9: 158-163.
Kass SU, Pruss D, Wolffe AP: How does DNA methylation repress transcription?. Trends Genet. 1997, 13: 444-449.
Riggs AD, Porter TN: Overview of epigenetic mechanisms. Epigenetic mechanisms of gene regulation. Edited by: Russo VEA, Martienssen RA, Riggs AD. 1996, Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 29-45.
Juttermann R, Li E, Jaenisch R: Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA. 1994, 91: 11797-11801.
Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, Muller MT, Davidson NE: Role of estrogen receptor gene demethylation and DNA methyltransferase. DNA adduct formation in 5-aza-2'-deoxycytidine-induced cytotoxicity in human breast cancer cells. J Biol Chem. 1997, 272: 32260-32266.
Creusot F, Acs G, Christman JK: Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine. J Biol Chem. 1982, 257: 2041-2048.
Michalowsky LA, Jones PA: Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance. Mol Cell Biol. 1987, 7: 3076-3083.
Santi DV, Norment A, Garrett CE: Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine. Proc Natl Acad Sci USA. 1984, 81: 6993-6997.
Herman JG, Merlo A, Mao L, Lapidus RR, Issa J-P, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995, 55: 4525-4530.
Otterson GA, Khleif SN, Chen W, Coxon AB, Kaye FJ: CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2' deoxycytidine. Oncogene. 1995, 11: 1211-1216.
Kingston RE, Narlikar GJ: ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. 1999, 13: 2339-2352.
Kornberg RD, Lorch Y: Chromatin-modifying and -remodeling complexes. Curr Opin Genet Dev. 1999, 9: 148-151.
Vignali M, Hassan AH, Workman JL: ATP-dependent chromatin-remodeling complexes. Mol Cell Biol. 2000, 20: 2167-2175.
Wu J, Grunstein M: 25 years after the nucleosome model: chromatin modifications. Trends Biochem Sci. 2000, 25: 619-623.
Spencer VA, Davie JR: Role of covalent modifications of histones in regulating gene expression. Gene. 1999, 240: 1-12.
Lee DY, Hayes JJ, Pruss D, Wolffe AP: A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell. 1993, 72: 73-84.
Vettesse-Dadey M, Grant PA, Hebbes TR, Crane-Robinson C, Allis CD, Workman JL: Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J. 1996, 15: 2508-2518.
Sanders LA, Schechter NM, McCarty KS: A comparative study of histone acetylation, histone deacetylation, and ribonucleic acid synthesis in avian reticulocytes and erythrocytes. Biochemistry. 1973, 12: 783-91.
Jackson V, Shires A, Chalkley R, Granner DK: Studies on highly metabolically active acetylation and phosphorylation of histones. J Biol Chem. 1975, 250: 4856-4863.
Csordas A: On the biological role of histone acetylation. Biochem J. 1990, 265: 23-38.
Inoue A, Fujimoto D: Histone deacetylase from calf thymus. Biochim Biophys Acta. 1970, 220: 307-316.
Kikuchi H, Fujimoto D: Multiplicity of histone deacetylase from calf thymus. FEBS Lett. 1973, 29: 280-282.
Vidali G, Boffa LC, Allfrey VG: Properties of an acidic histone-binding protein fraction from cell nuclei. Selective precipitation and deacetylation of histones F2A1 and F3. J Biol Chem. 1972, 247: 7365-7373.
Yoshida M, Kijima M, Akita M, Beppu T: Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by Trichostatin A. J Biol Chem. 1990, 265: 17174-17179.
Bird A: DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16: 6-21.
Chen ZJ, Pikaard CS: Epigenetic silencing of RNA polymerase I transcription: a role for DNA methylation and histone modification in nucleolar dominance. Genes Dev. 1997, 11: 2124-2136.
Lawrence RJ, Earley K, Pontes O, Silva M, Chen ZJ, Neves N, Viegas W, Pikaard CS: A concerted DNA methylation/histone methylation switch regulates rRNA gene dosage control and nucleolar dominance. Mol Cell. 2004, 13: 599-609.
Santoro R, Grummt I: Molecular mechanisms mediating methylation-dependent silencing of ribosomal gene transcription. Mol Cell. 2001, 8: 719-725.
Zhou Y, Santoro R, Grummt I: The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription. EMBO J. 2002, 21: 4632-4640.
Suzuki H, Gabrielson E, Chen W, Anbazhagan R, Van Engeland M, Weijenberg MP, Herman JG, Baylin SB: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet. 2002, 31: 141-149.
Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 1999, 21: 103-107.
Zhu WG, Otterson GA: The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells. Curr Med Chem Anti-Canc Agents. 2003, 3: 187-199.
Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB: Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature (London). 1979, 282: 615-616.
Knowles BB, Howe CC, Aden DP: Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 1980, 209: 497-499.
Bouma ME, Rogier E, Verthier N, Labarre C, Feldmann G: Further cellular investigation of the human hepatoblastoma-derived cell line HepG2: morphology and immunocytochemical studies of hepatic-secreted proteins. In Vitro Cell Dev Biol. 1989, 25: 267-75.
Kunnath L, Locker J: Developmental changes in the methylation of the rat albumin and alpha-fetoprotein genes. EMBO J. 1983, 2: 317-324.
Cassio D, Weiss MC: Expression of fetal and neonatal hepatic functions by mouse hepatoma-rat hepatoma hybrids. Somatic Cell Genet. 1979, 5: 719-738.
Dannenberg LO, Chen H-J, Tian H, Edenberg HJ: Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation. Alcohol Clin Exp Res. 2006, 30: 928-937.
Jones PA, Wolkowicz MJ, Rideout WM, Gonzales FA, Marziasz CM, Coetzee GA, Tapscott SJ: De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA. 1990, 87: 6117-6121.
Antequera F, Boyes J, Bird A: High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell. 1990, 62: 503-514.
Jones PA: DNA methylation errors and cancer. Cancer Res. 1996, 56: 2463-2467.
Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP: Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998, 72: 141-196.
Davuluri RV, Grosse I, Zhang MQ: Computational identification of promoters and first exons in the human genome. Nat Genet. 2001, 29: 412-417.
CpG Island Finder: [http://bioinformatics.med.ohio-state.edu/CpGisland/]
Taupenot L, Harper KL, O'Connor DT: The chromogranin-secretogranin family. N Eng J Med. 2003, 348: 1134-1149.
Bartolomei MS, Tilghman SM: Genomic imprinting in mammals. Annu Rev Genet. 1997, 31: 493-525.
Bell AC, Felsenfeld G: Methylation of a CTCF-dependent boundary controls imprinted expression of the igf2 gene. Nature. 2000, 405: 482-485.
Pant V, Mariano P, Kanduri C, Mattson A, Lobanenkov VV, Heuchel R, Ohlsson R: The nucleotides responsible for the direct physical contact between the chromatin insulator protein CTCF and the H19 imprinting control region manifest parent of origin-specific long-distance insulation and methylation-free domains. Gene Dev. 2003, 17: 586-590.
Thorvaldsen JL, Duran KL, Bartolomei MS: Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev. 1998, 12: 3693-3702.
Dasari VK, Deng D, Perinchery G, Yeh CC, Dahiya R: DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer. J Urol. 2002, 167: 335-338.
Schnieders F, Dork T, Arnemann J, Vogel T, Werner M, Schmidtke J: Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet. 1996, 5: 1801-1807.
Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, Fox EJ, Culhane AC, McArdle L, Fraga MF, Hughes L, Currid CA, O'Mahony F, Byrne A, Murphy AA, Moss C, McDonnell S, Stallings RL, Plumb JA, Esteller M, Brown R, Dervan PA, Easty DJ: Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptome studies. Carcinogenesis. 2005, 26: 1856-1867.
Reijo R, Lee TY, Salo P, Alagappan R, Brown LG, Rosenber M, Rozen F, Jaffe T, Straus D, Hovatta O: Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet. 1995, 10: 383-393.
Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, Kohn FM, Schill WB, Farah S, Ramos C, Hartmann M, Hartschuh W, Meschede D, Behre HM, Castel A, Nieschlag E, Weidner W, Grone HJ, Jung A, Engel W, Haidl G: Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet. 1996, 5: 933-943.
Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD: Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet. 2001, 27: 383-391.
Wrighton SA, Vandenbranden M: Isolation and characterization of human fetal liver cytochrome P450HLp2: a third member of the P450III gene family. Arch Biochem Biophys. 1989, 268: 144-151.
Voigt KD, Bartsch W: Intratissular androgens in benign prostatic hyperplasia and prostatic cancer. J Steroid Biochem. 1986, 25: 749-57.
Yang S, Fang Z, Suzuki T, Sasano H, Zhou J, Gurates B, Tamura M, Ferrer K, Bulun S: Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase. J Clin Endocrinol Metab. 2002, 87: 2336-2345.
Picado-Leonard J, Miller WL: Cloning and sequence of the human gene for P450c17 (steroid 17 -hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA. 1987, 6: 439-48.
Baer M, Williams SC, Dillner A, Schwartz RC, Johnson PF: Autocrine signals control CCAAT/enhancer binding protein β expression, localization, and activity in macrophages. Blood. 1998, 92: 4353-4365.
Buck M, Turler H, Chojkier M: LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation. EMBO J. 1994, 13: 851-860.
Descombes P, Schibler U: A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell. 1991, 67: 569-579.
Ossipow V, Descombes P, Schibler U: CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci USA. 1993, 90: 8219-8223.
Dearth LR, Hutt J, Sattler A, Gigliotti A, DeWille J: Expression and function of CCAAT/enhancer binding protein β (C/EBP β) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells. J Cell Biochem. 2001, 82: 357-370.
Cooper C, Henderson A, Artandi S, Avitahi N, Calame K: Ig/EBP (C/EBP gamma) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Res. 1995, 23: 4371-4377.
Dinic S, Bogojevic D, Petrovic M, Poznanovic G, Ivanovic-Matic S, Mihailovic M: C/EBP alpha and C/EBP beta regulate haptoglobin gene expression during rat liver development and the acute-phase response. Mol Biol Rep. 2005, 32: 141-147.
Shiojiri N, Takeshita K, Yamasaki H, Iwata T: Suppression of C/EBP alpha expression in biliary cell differentiation from hepatoblasts during mouse liver development. J Hepatol. 2004, 41: 790-798.
Liang G, Gonzalgo ML, Salem C, Jones PA: Identification of DNA methylation differences during tumorigenesis by methylation-sensitive arbitrarily primed polymerase chain reaction. Methods. 2002, 27: 150-155.
Affymetrix support: [http://www.affymetrix.com/support/technical/manual/expression_manual.affx]
Breese MR, Stephens MJ, McClintick JN, Grow MW, Edenberg HJ: Labrat LIMS: An extensible framework for developing laboratory information management, analysis, and bioinformatics solutions for microarrays [abstract]. SAC. 2003, 103-108.
Gene Expression Omnibus: [http://www.ncbi.nlm.nih.gov/projects/geo/]
McClintick JN, Edenberg HJ: Effects of filtering by present call on analysis of microarray experiments. BMC Bioinformatics. 2006, 7: 49-
McClintick JN, Jerome RE, Nicholson CR, Crabb DW, Edenberg HJ: Reproducibility of oligonucleotide arrays using small samples. BMC Genomics. 2003, 4: 4-
Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B. 1995, 57: 289-300.
Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998, 95: 14863-14868.
NCBI BLAST: [http://www.ncbi.nlm.nih.gov/BLAST/]